mol42
09 Jul 2018
Holdings RNS jees at least someone follows this bb on another bb thx parob - or perhaps not - lol mol
mol42
09 Jul 2018
Holdings RNS as at 060718 As at 6 July 2018, significant shareholders that hold more than 3% of the share capital of OptiBiotix Health Plc, and shareholdings of any other directors are detailed below: Number Ordinary Shares % Stephen O’Hara (Director) 10,103,029 12.19 Finance Yorkshire Seedcorn Fund (FYSCF) 9,449,314 11.40 Michael McGeever 2,532,142 3.05 Stephen O’Hara holds 6,099,135 shares under Options we have the very welcome addition of Mr Michael McGeever but also no change to FYSCF another month when they haven’t been selling - don’t you just love the speculation on other bulletin boards! hmmm perhaps not - lol - as all the usual posters have gone apart from elrico and me - cheers to him and thx sometimes you just get lucky…? we will see mol
elrico63
08 Jul 2018
Rns - identification? Mol - As you can now see now, the source is NOT anyone from OPTI BOD, but someone reporting to be “close to OPTI†whatever that means. I have manage to clear this up by way of a Q&A in the link I posted in your other post and here for convenience. [link]
elrico63
08 Jul 2018
Rns - identification? lemminginvestors.blogspot.com OptiBiotix - Mike McGeever A brief Q&A with Mike McGeever First of all, thank you Mike for agreeing to the Q&A at such short notice. You mak...
mol42
07 Jul 2018
Rns - identification? i do - they released an rns having received a notification from an individual having the first name Mike and surname McGeever now a michael caine film springs to mind… my name is … or how about my name is actually the archbish… of canter… mol
mol42
07 Jul 2018
Rns - identification? went to the trouble of writing it down Essentially TW saying i’m wrong for suggesting he identified the wrong Mike McGeever responsible for the TRI on friday. Odd, because i’m in regular contact with Mike and he, himself, confirmed TW has identified the wrong Mike McGeever. Rather worringly it’s not TW that is wrong but opti bod. Make of that what you will. mol
mol42
07 Jul 2018
Rns - identification? jees i’ve just read your post on advfn elrico - 070718 19.29 unfortunately cannot copy and paste from there just doesn’t make sense at all - total contradiction lol and then to blame opti BOD - jees if you still read this bb perhaps you can explain our co released a holding rns regarding an individual increasing his holding over 3% wish i had his money - but at least i continue to have his belief in our bod mol
mol42
02 Jul 2018
Clinical Trial lpldl picked up from another bb but here is clinical trial link clinicaltrials.gov The Efficacy of Cholesterol-lowering Probiotic Lactobacillus Planetarium in... The Efficacy of Cholesterol-lowering Probiotic Lactobacillus Planetarium in Adults With High Cholesterol - Full Text View. obviously with our go ahead anyway lots of news before estimated trial completion date and then thereafter subsequent results perhaps this time referring to company concerned - lol mol
mol42
29 Jun 2018
Large Trades this pm 17
5:56 29-Jun-2018 65.50 GBX 1,317,500 862,962.50 Off-book XOFF LRGS mol
mol42
29 Jun 2018
Large Trades this pm |15:18:26 29-Jun-2018 |60.00 |GBX |111,408 |66,844.80 |Off-book |AIMX |LRGS| |15:164 29-Jun-2018 |60.00 |GBX |1,350,000 |810,000.00 |Off-book |AIMX |LRGS| |15:148 29-Jun-2018 |60.00 |GBX |1,461,408 |876,844.80 |Off-book |AIMX |LRGS| |15:10:57 29-Jun-2018 |65.00 |GBX |50,000 |32,500.00 |Off-book |AIMX |LRGS| including sale of options exercised 14 Jun 18 at 8p mol
mol42
26 Jun 2018
Slimbiome back in stock [[link] mol
mol42
26 Jun 2018
Year End 301117 the healthy weight loss company - accounts now filed available below [[link] a lot of work still to be done but an element of progress made to 30 11 17 and hopefully a lot more since 301117 - Christina was only appointed as we know in July 17 mol
mol42
26 Jun 2018
RNS Sweetbiotix Agreement with global corporate for SweetBiotix® OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, announces that it has entered into an agreement with a global corporate for its SweetBiotix® low calorie sweet fibres. The agreement sets out the terms and grants exclusivity, for a period of six months, to negotiate a license agreement for the scale up, manufacture and distribution of its SweetBiotix® low calorie sweet fibres. OptiBiotix will receive monthly payments during this exclusivity period amounting to a six figure sum. OptiBiotix has previously announced (RNS: 27 March 2018) that it has carried out five successful human taste studies on a range of products developed from its SweetBiotix® development programmes. This has created interest from a number of corporates with expertise in the manufacture and commercialisation of speciality ingredients and/or consumer products. This agreement reflects the materialisation of interest from one of these companies in scaling up, manufacturing and distributing SweetBiotix® from one of its development programmes. The company is a global supplier of nutritional and agricultural products to companies around the world with an annual turnover exceeding $100bn. The organisation requires its identity and the terms of the agreement to remain confidential and no further details can be disclosed. A further announcement will be made in due course. Step hen O’Ha r a, CEO of O pti B i oti x, c o mmented: “We are pleased to announce the signing of this agreement for SweetBiotix ® with one of the world’s largest suppliers of nutritional and agricultural products . This is the second agreement with global partners for products created from our SweetBiotix ® development programmes. This is part of a strategy of working with global partners to support scale up, manufacture and commercialisation of a range of SweetBiotix ® products in well-known consumer brands. With international concerns over the balance of sugars and fibres in consumer diets rising, OptiBiotix’s is at the forefront of product development in this area of growing industry and commercial interest.†coming thick and fast mol
elrico63
22 Jun 2018
Chat with Per of OptiBiotix Yesterday (Thursday) I had chance to catch up with Per – he offers some very useful insight into the workings of the industry OptiBiotix are penetrating. I think as investors it can be difficult to grasp the intricacies of these markets and how company’s the size of OptiBiotix progressing in a market dominated by company’s much greater in size and stature, most of which have been established for many years. … lemminginvestors.blogspot.com OptiBiotix - Per Rehné chat Yesterday (Thursday) I had chance to catch up with Per – he offers some very useful insight into the workings of the industry Opti...
elrico63
21 Jun 2018
Commercial progresss some thoughts on [link]
